# Revisions to the Requirements Applicable to Blood, Blood Components, and Source Plasma; Confirmation in Part and Technical Amendment
> **Food and Drug Administration** · Direct final rule; confirmation in part and technical amendment. · Published 2001-01-10 · Effective 1999-08-19 · 66 FR 1834
## Document
- **Document number:** 01-533
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 66 FR 1834
- **CFR reference:** 21 CFR 606
- **Publication date:** 2001-01-10
- **Effective date:** 1999-08-19
- **HHS docket:** Docket No. 98N-0673
## Abstract

The Food and Drug Administration (FDA) is confirming in part the direct final rule issued in the Federal Register of August 19, 1999. The direct final rule amends the biologics regulations by removing, revising, or updating specific regulations applicable to blood, blood components, and Source Plasma to be more consistent with current practices in the blood industry and to remove unnecessary or outdated requirements. FDA is confirming the provisions for which no significant adverse comments were received. The agency received significant adverse comments on certain provisions and is amending Title 21 Code of Federal Regulations to reinstate the former provisions.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2001/01/10/01-533/revisions-to-the-requirements-applicable-to-blood-blood-components-and-source-plasma-confirmation-in)
---
*AI Analytics · CC0 1.0*